日本放射性药物市场报告（按产品类型、应用、最终用途和地区划分，2026-2034年）

Japan Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本放射性药物市场规模达2.807亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到6.422亿美元，2026年至2034年间的复合年增长率（CAGR）为9.63%。癌症、心血管疾病和神经系统疾病等慢性病盛行率的上升，导致对诊断和治疗放射性药物的需求增加，从而推动了市场成长。

本报告解答的关键问题：

日本放射性药物市场迄今表现如何？未来几年又将如何发展？
新冠疫情对日本放射性药物市场产生了哪些影响？
日本放射性药物市场依产品类型分類的组成是怎样的？
日本放射性药物市场按应用领域分類的组成是怎样的？
日本放射性药物市场以最终用途分類的构成是怎样的？
日本放射性药物市场价值链的各个阶段有哪些？
日本放射性药物产业的主要驱动因素和挑战是什么？
日本放射性药物市场的结构是怎么样的？主要参与者有哪些？
日本放射性药物市场的竞争程度如何？

Japan radiopharmaceuticals market size reached USD 280.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 642.2 Million by 2034, exhibiting a growth rate (CAGR) of 9.63% during 2026-2034. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions that has led to an increased demand for diagnostic and therapeutic radiopharmaceuticals, is driving the market.

Radiopharmaceuticals are specialized drugs that contain a radioactive component, typically a small amount of a radioactive isotope, combined with a biologically active molecule. They are used in nuclear medicine for diagnostic and therapeutic purposes. In diagnostic applications, radiopharmaceuticals are administered to patients, and their radioactive emissions are detected using imaging equipment like gamma cameras or PET scanners. This allows healthcare professionals to visualize and assess various physiological processes within the body, such as blood flow, organ function, or the presence of specific diseases like cancer. Radiopharmaceuticals can also be used in therapeutic applications to treat certain medical conditions, such as thyroid disorders and some types of cancer. In these cases, the radioactive component is targeted to specific cells or tissues to deliver a localized dose of radiation, which can destroy or control the growth of abnormal cells. Overall, radiopharmaceuticals play a crucial role in modern medicine by providing valuable information for diagnosis and offering effective treatment options for specific diseases, all while minimizing radiation exposure to surrounding healthy tissues.

Japan Radiopharmaceuticals Market Trends:

The radiopharmaceuticals market in Japan is experiencing robust growth due to several key drivers. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has propelled the demand for diagnostic and therapeutic radiopharmaceuticals. Additionally, the growing aging population in Japan has augmented the need for advanced diagnostic tools, further fueling market expansion. Moreover, technological advancements in radiopharmaceutical production and imaging techniques have made these agents safer and more effective, boosting their adoption rates among healthcare providers. Furthermore, a rising awareness among both healthcare professionals and patients about the benefits of early disease detection and targeted therapy has contributed to the market's growth. Collaborative efforts between pharmaceutical companies and research institutions to launch novel radiopharmaceuticals have also propelled market expansion. Furthermore, the expanding application of radiopharmaceuticals in personalized medicine and their potential for precision treatment strategies, which have opened up new avenues for market development, is expected to drive the market in Japan in the coming years.

Japan Radiopharmaceuticals Market Segmentation:

Product Type Insights:

Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

Application Insights:

Oncology
Cardiology
Neurology
Endocrinology
Others

End Use Insights:

Hospitals and Clinics
Research Institutes
Diagnostic Centers

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan radiopharmaceuticals market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan radiopharmaceuticals market?
What is the breakup of the Japan radiopharmaceuticals market on the basis of product type?
What is the breakup of the Japan radiopharmaceuticals market on the basis of application?
What is the breakup of the Japan radiopharmaceuticals market on the basis of end use?
What are the various stages in the value chain of the Japan radiopharmaceuticals market?
What are the key driving factors and challenges in the Japan radiopharmaceuticals?
What is the structure of the Japan radiopharmaceuticals market and who are the key players?
What is the degree of competition in the Japan radiopharmaceuticals market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiopharmaceuticals Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Radiopharmaceuticals Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Radiopharmaceuticals Market - Breakup by Product Type

6.1 Diagnostic Nuclear Medicine
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Therapeutic Nuclear Medicine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan Radiopharmaceuticals Market - Breakup by Application

7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Cardiology
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Neurology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Endocrinology
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2020-2025)
- 7.5.2 Market Forecast (2026-2034)

8 Japan Radiopharmaceuticals Market - Breakup by End Use

8.1 Hospitals and Clinics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Diagnostic Centers
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan Radiopharmaceuticals Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product Type
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End Use
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product Type
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End Use
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product Type
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End Use
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product Type
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End Use
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product Type
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End Use
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product Type
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End Use
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product Type
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End Use
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product Type
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End Use
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Radiopharmaceuticals Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Radiopharmaceuticals Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis